 |
|
|
|
|
|
|
|
|
|
|
 |
|
|||||||||
 |
 |
 |
|
|||||||
 |
 |
 |
 |
 |
 |
 |
|
|||
 |
 |
|
||||||||
Jeffrey D. Wager, MD
President and Chief Executive Officer Georg Nebgen, PhD, Director John Costantino, Director Hironori Hozoji, Director Philippe Chambon, MD, PhD, Director Heng-Tong Choo, Director Gary Shearman, PhD, Director Board of DirectorsGeorg Nebgen, PhD, Director Dr. Georg Nebgen is a Managing General Partner and co-founder of NGN Capital. He most recently was at MPM Capital, serving as Principal at MPM Capital in Boston and Managing Director of MPM Capital GmbH. Prior to MPM Capital, Dr. Nebgen served as Managed Care Area Manager for New England with Schering-Plough Corporation. His responsibilities included contracting the reimbursement of Schering-Plough's ethical pharmaceutical products and services with managed care organizations as well as leading sales pull-through activities of the field forces. Earlier, he worked at Schering-Plough's subsidiary in Switzerland as Business Unit Head, Oncology & Biotech and Business Unit Head, Cardiovascular & CNS. Dr. Nebgen came to Schering-Plough from F. Hoffmann-La Roche, where as Technical Project Leader he led the global research and development team for Invirase/Fortovase, its NDA filing, FDA approval and subsequent product launch in the United States. Dr. Nebgen earned his doctorate in pharmaceutical technology sciences from the University of Bonn, Germany, and his executive MBA from the University of St. Gallen, Switzerland. He is the recipient of awards in both science and business. The former President of the German-American Business Council in Boston, Dr. Nebgen now serves on the boards of Artisan, Javelin (observer), KIKA and Santhera, and previously served on the boards of Aerovance (observer), Kourion and Omrix.  |
||||||||||
 |
|
|||||||||